Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel

Climacteric

Volumn 6, Issue 1, 2003, Pages 75-80

  Vinker, S ^a,b,c   Kaplan, B ^a   Yaphe, J ^a,b   Cohen, O ^a,b   Shumla, V ^a,b   Shapira, G ^a,b   Shofty, I ^a,b   Kitai, E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c NONE   (Israel)

Author keywords

Family Practice; Hormone Replacement Therapy; Prevalence; Sociodemographic Factors

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENERAL PRACTICE; HEALTH STATUS; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MENOPAUSE; MULTICENTER STUDY; MULTIPLE REGRESSION; OBESITY; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL STATUS; TREATMENT INDICATION;

EID: 0347926104     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.6.1.75.80     Document Type: Article

References (22)

1. Clinical Synthesis Panel on HRT. Hormone replacement therapy. Lancet 1999;354:152-5
2. Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999;130:545-53
3. MacLennan AH, Wilson DH, Taylor AW. Hormone replacement therapy: prevalence, compliance and the 'healthy women' notion. Climacteric 1998;1:42-9
4. North FM, Sharples K. Changes in the use of hormone replacement therapy in New Zealand from 1991-1997. NZ Med J 2001;114:250-3
5. Moorhead T, Hannaford P, Warskyj M. Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol 1997;104:290-7
6. Harris TJ, Cook DG, Wicks PD, Cappuccio FP. Ethnic differences in use of hormone replacement therapy: community based survey. Br Med J 1999;319:610-11
7. Manson JE, Martin KA. Postmenopausal hormone-replacement therapy. N Engl J Med 2001;345:34-40
8. Shah S, Harris TJ, Cook DG. Differences in hormone replacement therapy use by social class, region and psychological symptoms. Br J Obstet Gynaecol 2001;108:269-75
9. Duetz MS, Abel T, Meier C, Niemann S. Self-rated health, life satisfaction and personal characteristics of postmenopausal women under estrogen replacement therapy. Maturitas 2000;35:71-9
10. Connelly MT, Richardson M, Platt R. Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995. J Gen Intern Med 2000;15:542-50
11. Finley C, Gregg EW, Solomon LJ, Gay E. Disparities in hormone replacement therapy use by socio-economic status in a primary care population. Community Health 2001;26:39-50
12. Blumberg G, Kaplan B, Rabinerson D, Goldman GA, Kitai E, Neri A. Women's attitudes towards menopause and hormone replacement therapy. Int J Gynecol Obstet 1996;54:271-7
13. Israel Center for Disease Control. Women's Health in Israel 1999-2000: Data Book. Tel Aviv: Israel Center for Disease Control, 2001:49
14. Ettinger B, Woods NF, Barrett-Connor E, Pressman A. The North American Menopause Society 1998 menopause survey: Part II. Counseling about hormone replacement therapy: association with socioeconomic status and access to medical care. Menopause 2000;7:143-8
15. Huston S, Sleath B, Rubin RH. Physician gender and hormone replacement therapy discussion. J Women's Health Gend Based Med 2001;10:279-87
16. Griffiths F. Women's decisions about whether or not to take hormone replacement therapy: influence of social and medical factors. Br J Gen Pract 1995;45:477-80
17. Roberts PJ, Sibbald B. Hormone replacement therapy: the views of general practitioners and practice nurses. Br J Gen Pract 2000;50:986-91
18. Andersson K, Pedersen AT, Mattsson LA, Milsom I. Swedish gynecologists' and general practitioners' views on the climacteric period: knowledge, attitudes and management strategies. Acta Obstet Gynecol Scand 1998;77:909-16
19. Brookdale Institute. Women's Health and Welfare in Israel: National Survey Findings. Jerusalem: Brookdale Institute, 2000:11-17
20. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestins in healthy postmenopausal women: principal results from Women's Health Initiative randomized controlled trial J Am Med Assoc 2002;288:321-33
21. Matthews KA, Kuller LH, Wing RK, Meilahn EN, Plantinga P. Prior use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996;143:971-8
22. Mattsson LA, Stadberg E, Milsom I. Management of hormone replacement therapy: the Swedish experience. Eur J Obstet Gynecol Reprod Biol 1996;64(Suppl):S3-5